Variant report
Variant | esv3413775 |
---|---|
Chromosome Location | chr5:120704953-120708351 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs547688258 | chr5:120705245-120705246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs77779747 | chr5:120705275-120705276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs78033036 | chr5:120705288-120705289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs114867468 | chr5:120705289-120705290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs528357967 | chr5:120705338-120705339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs546919672 | chr5:120705439-120705440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs148376147 | chr5:120705456-120705457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs141429766 | chr5:120705459-120705460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs181336901 | chr5:120705468-120705469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536453400 | chr5:120705474-120705475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569310905 | chr5:120705519-120705520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536367676 | chr5:120705563-120705564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554508840 | chr5:120705569-120705570 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572910383 | chr5:120705608-120705609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540475040 | chr5:120705624-120705625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10478514 | chr5:120705640-120705641 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs577156927 | chr5:120705641-120705642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs147032361 | chr5:120705706-120705707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs62382634 | chr5:120705711-120705712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs530596240 | chr5:120705729-120705730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs78260362 | chr5:120705737-120705738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs373579737 | chr5:120705759-120705760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113171563 | chr5:120705766-120705767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs368144572 | chr5:120705775-120705776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs246208 | chr5:120705784-120705785 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs532334480 | chr5:120705789-120705790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs143888335 | chr5:120705801-120705802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs74917930 | chr5:120705810-120705811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs571813032 | chr5:120705860-120705861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs189968546 | chr5:120705873-120705874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs78780161 | chr5:120705897-120705898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs566668693 | chr5:120705906-120705907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs534294716 | chr5:120705934-120705935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs61110338 | chr5:120705993-120705994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs570974909 | chr5:120707438-120707439 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
36 | rs531598524 | chr5:120707458-120707459 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
37 | rs77823393 | chr5:120707465-120707466 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
38 | rs77325534 | chr5:120707499-120707500 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
39 | rs536178609 | chr5:120707517-120707518 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
40 | rs554371146 | chr5:120707535-120707536 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
41 | rs75867609 | chr5:120707551-120707552 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
42 | rs533825210 | chr5:120707557-120707558 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
43 | rs139868470 | chr5:120707571-120707572 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
44 | rs576908811 | chr5:120707573-120707574 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
45 | rs543844082 | chr5:120707582-120707583 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
46 | rs78730013 | chr5:120707589-120707590 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Glaucoma | 21310917 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:120705200-120706000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr5:120707400-120707600 | Bivalent Enhancer | Esophagus | oesophagus |